U2 Femoral component, PS 2103-3260Recalls & reported problems
United Orthopedic Corp. · U2 Femoral component, PS, #6, right · Class 2 · Implant
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 04712602345712), received between May 28, 2026 and May 28, 2026 — classified as 1 injury.
The most frequently reported specific device problem is “Loosening of Implant Not Related to Bone-Ingrowth” (1 report).
1 other recall cover devices cleared under the same FDA submission (K051640); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Loosening of Implant Not Related to Bone-Ingrowth1
Patient problems
- Limb Pain1
- Medical device site infection1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryMay 28, 2026Loosening of Implant Not Related to Bone-Ingrowth
AN ADVERSE EVENT REGARDING THE FEMORAL COMPONENT WAS RECEIVED ON (B)(6) 2026. A 70-YEAR-OLD MALE PATIENT UNDERWENT RT. TKA SURGERY USING THE U2 TOTAL KNEE SYSTEM ON (B)(6) 2025. THE PROCEDURE WAS UNEVENTFUL, AND THE PATIENT WAS DISCHARGED IN STABLE CONDITION WITH REGULAR FOLLOW-UP. THE PATIENT HAS EXPERIENCED PAIN IN THE RIGHT KNEE JOINT SINCE (B)(6) 2026. THE TEST RESULTS OF THE JOINT ASPIRATE INDICATED STREPTOCOCCUS ANGINOSUS INFECTION, AND IMAGING STUDIES REVEALED A RADIOLUCENT LINE AROUND THE IMPLANT. DUE TO SEPTIC LOOSENING OF THE IMPLANT, DEBRIDEMENT AND REVISION SURGERY WERE PERFORMED ON (B)(6) 2026, FOLLOWED BY ANTIMICROBIAL THERAPY.
Patient problems: Limb Pain; Medical device site infection
MAUDE report 25313004 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K051640. One submission often covers many models, so check the product and lot details in each record.
- Z-1128-2018 · Nov 24, 2017 · TerminatedU2 Total Knee System Tibial Insert, Posterior Stabilized, #3, 11mm Thick Catalogue number 2303-3032 The U2 Total Knee system is indicated in knee arthroplasty for reduction or rel
Other Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Cemented, Polymer/Metal/Polymer devices
- ATTUNE 1506-00-005Depuy (Ireland) · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER589 reports
- ATTUNE 1506-00-004Depuy (Ireland) · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER580 reports
- JOURNEY 74012812Smith & Nephew, Inc. · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER502 reports
- JOURNEY 74011856Smith & Nephew, Inc. · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER438 reports
- PERSONA™ 42-5099-094-00Zimmer, Inc. · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER406 reports
- JOURNEY 74011857Smith & Nephew, Inc. · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER388 reports
- ATTUNE 1506-00-007Depuy (Ireland) · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER288 reports
- ATTUNE 1506-00-003Depuy (Ireland) · PROSTHESIS, KNEE, PATELLOFEMOROTIBIAL, SEMI-CONSTRAINED, CEMENTED, POLYMER/METAL/POLYMER271 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page